Modulating Crystallization and Defect Passivation by Butyrolactone Molecule for Perovskite Solar Cells

4Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.

Abstract

The attainment of a well-crystallized photo-absorbing layer with minimal defects is crucial for achieving high photovoltaic performance in polycrystalline solar cells. However, in the case of perovskite solar cells (PSCs), precise control over crystallization and elemental distribution through solution processing remains a challenge. In this study, we propose the use of a multifunctional molecule, α-amino-γ-butyrolactone (ABL), as a modulator to simultaneously enhance crystallization and passivate defects, thereby improving film quality and deactivating nonradiative recombination centers in the perovskite absorber. The Lewis base groups present in ABL facilitate nucleation, leading to enhanced crystallinity, while also retarding crystallization. Additionally, ABL effectively passivates Pb2+ dangling bonds, which are major deep-level defects in perovskite films. This passivation process reduces recombination losses, promotes carrier transfer and extraction, and further improves efficiency. Consequently, the PSCs incorporating the ABL additive exhibit an increase in conversion efficiency from 18.30% to 20.36%, along with improved long-term environmental stability. We believe that this research will contribute to the design of additive molecular structures and the engineering of components in perovskite precursor colloids.

Cite

CITATION STYLE

APA

Wang, F., Du, J., Zhao, C., Li, Y., Wei, M., Liu, H., … Yang, L. (2023). Modulating Crystallization and Defect Passivation by Butyrolactone Molecule for Perovskite Solar Cells. Molecules, 28(14). https://doi.org/10.3390/molecules28145542

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free